Our Team

When MedTEC Pharma’s co-founders had the vision to bring cannabis to the medicinal mainstream, they knew they would need to take on a considerable mission: building a professional, pharmaceutical cannabis business from the ground up.

As close associates for over 20-years, Brad Gallard and Richard Barrett were a formidable combination of complementary strengths – Brad with extensive expertise in agribusiness and manufacturing, and Richard with health and medical industry expertise backed by 20 years of international business experience.

Together they leveraged their skills to assemble a team of leading experts and strategic partners, all with the capabilities to address the gaps in this nascent industry.

Leadership Team

Richard Barrett
Co-founder and CEO

Richard brings extensive capability to the building and structuring of a health and manufacturing business.

He previously led the industry cluster MedTEC South Australia, an internationally active alliance of medical technology leaders, researchers and investors. He combines this with 25 years’ experience in building international businesses and global value chain management and technology.

Richard was responsible for building MedTEC Pharma’s world class team of industry leaders and research partners. He continues to develop these partnerships, as well as strengthen the business’s position with our stakeholders and the community.

Credentials and experience

  • 25 years international experience in global value chain management, business and brand development with senior leadership in the medical technology sector
  • Member – SA Government Ministerial Advisory Panel for Health and Medical Industries
  • Chair – Harrison McMillan Pty Ltd
  • Board Director – Vinehealth Australia
  • Former Chair  – MedTEC South Australia Inc.
  • Former Past Vice President – Scholle Corporation
  • Former Chair – Northern Adelaide Economic Development Board

Brad Gallard
Co-founder and COO

Brad is no stranger to innovation and enterprise. He brings third generation agri-business expertise, along with his experience building and operating leading food and beverage manufacturing businesses at scale.

Brad is responsible for developing a program for delivery of the entire supply chain, from cultivation through to manufacturing and distribution. He has provided the business with a strong foundation for scalable production and manufacturing to dedicated market specifications.

Credentials and experience

  • Managing Director – Gallard Holdings (third-generation horticulture company)
  • Former Board Director – Citrus Board of South Australia
  • Former Board Director – Citrus Growers of SA
  • Former Board Director – Renmark Irrigation Trust

Dirk Beelen
Chief Commercial Officer

Dirk has over 30 years experience in international pharmaceuticals and medical devices, where he has a strong track record in commercialising new and disruptive products.

He has also worked in the South Australian state government as Director of Health and Medical Industries, which has given him a comprehensive view of the cannabis industry’s evolution.

Dirk’s depth of experience has provided MedTEC Pharma with objective, measured and invaluable advice in the business’s ongoing development.

Credentials and experience

  • 30 years’ experience in international pharmaceuticals and medical devices
  • Past Vice President Sales & Marketing – Johnson & Johnson Europe
  • Immediate Past Director – Health & Medical Industries, SA Government
  • Former member – University of Adelaide Health and Biotech Advisory Board

Derek Pfitzner
Area Manager

Derek leads MedTEC Pharma’s operations in the Riverland.

His major beverage company manufacturing experience delivers exceptional capability in quality compliance and systems. Derek has extensive expertise in Lean manufacturing and Six Sigma to ensure manufacturing best practice.

Credentials and experience

  • Immediate past Manufacturing Manager / Site Leader – Asahi Beverages (The Better Drinks Co)
  • Played a key leadership role in establishing a fully automated fruit juice beverage plant in Regional South Australia.
  • Former Production Manager / Site Leader – Charlies Group Australia
  • Operations, capex budget management, site and team expansion from extensive experience in establishment of systems and processes, including (HACCP, ISO9001, AS14001, ASAHI MR-GR/Lean/OES, EHS)

Strategic Advisory Board

MedTEC Pharma has secured a first class advisory board of clinical, public health and industry experts.

This group of internationally acclaimed individuals enables the business to create market pathways through the deployment of core intellectual property. This ensures MedTEC Pharma’s work will directly benefit patients whilst optimising revenue.

Mark Harvey
Chair of Advisory Board

Mark’s expertise in patenting seed genetics delivers MedTEC Pharma a significant competitive advantage.

His experience commercialising intellectual property includes a position as Chairman of a NASDAQ Agri / Seed Business, as well as Independent Director of ASX-listed Duxton Broad Acre Farms.

He has a comprehensive understanding of how to patent all components of a plant, providing MedTEC Pharma with the capability to develop a comprehensive IP strategy.

Credentials and experience

  • Chairman – S&W Seed Co (NASDAQ: SANW)
  • Deputy Chair – Duxton Broadacre Farms (ASX: DBF)
  • Member – Agribusiness Advisory Board, Adelaide University

Ray Blight
Deputy Chair of Advisory Board

A key component of MedTEC Pharma’s work is to bring medicinal cannabis to the public health system. Ray Blight has a formidable background in public health leadership, which provides the business with a crucial pathway to this market.

Ray has run South Australia’s public hospitals in his role as CEO of the South Australian Health Commission. He is also highly regarded in the corporate domain as previous advisor at World Bank and founder of Alcidion Corp, a publicly listed company.

Credentials and experience

  • Chair – NAHLN (SA Health)
  • Founder – Alcidion Corp (ASX: ALC)
  • Past CEO – SA Health Commission
  • Past Advisor – World Bank
  • Past Executive Director – Bankers Trust

Mathew Palmer
BSc (Hons)

For MedTEC Pharma to succeed as a pharmaceutical company, it needs to strategically navigate the clinical trials and regulatory pathway.

Mathew has over 26 years in drug development across all phases of research in multiple indications; including pain. A key focus is in drug development and commercialisation.

His advice will prove invaluable in de-risking the pathway through the clinical trials process in an effective and economical manner to support our corporate objectives for a high quality and validated medicinal cannabis product.

Credentials and experience

  • Chair – AusBiotech SA
  • Member – SA State Advisory Board for Clinical Trials and Pharma
  • Member – Commercialisation Professionals Adelaide

Anna McClure
MPharm FSHP BCPS

Anna provides MedTEC Pharma with comprehensive pharmaceutical experience; spanning the medicinal and the commercial components of the industry.

As Executive Director of SA Pharmacy (a branch of SA Health), she provides essential capability in bringing a pharmaceutical product into the public domain.

Like many members of the Advisory Board, Anna was initially a medicinal cannabis sceptic. This inclination to be aporetic is an essential characteristic of all board members, as it ensures we meet the conditions to achieve our objectives.

Credentials and experience

  • Executive Director – SA Pharmacy (SA Health)
  • Hospital Pharmacy Lead – South Australian Medicines Advisory Committee

Prab Takhar
MSc Medical Physics, MSc (Hons) Physics, MPhil Radiation & Medical Imaging

Prab provides expertise in the highly regulated process of turning genetic plant material into medicine. Prab was previously head of Molecular Imaging and Therapy Research Unit at SAHMRI, and remains adjunct director of this platinum-standard research institute.

His work with MedTEC Pharma includes essential advice on creating a TGA- and GMP-certified manufacturing environment.

Credentials and experience

  • Head of Cyclotron Unit – University Hospital-Linkoping (Sweden)
  • Adjunct Director – Molecular Imaging and Therapy Research Unit (MITRU), SAHMRI
  • Previously Global Tracer Centre Project Lead – GE Healthcare
  • Medical Physicist, NHS (UK)

Clinical Leadership

Until recently, cannabis has been subject to a highly prohibitive environment, which has prevented the gathering of science-based clinical evidence.

One of MedTEC Pharma’s key differentiators is its investment in clinical trials, in an effort to ensure product uptake by the broader pharmaceutical industry.

Professor Paul Rolan
Principal Clinical Investigator and Lead Regulatory Consultant

Paul plays a critical role advising MedTEC Pharma on clinical trials and access to the Therapeutic Goods Administration (TGA).

He is a drug development consultant with extensive expertise 
in early phase medicine development. He has been principal investigator in hundreds of early phase, clinical pharmacology, drug interactions and special patient groups studies.

Paul will provide valuable input into the design, site selection, management and interpretation of data from experimental medicine studies.

Credentials and Experience

  • Professor of Clinical Pharmacology and Director of Innovation – Health and Medical Sciences, University of Adelaide
  • Fellow – Royal Australasian College of Physicians
  • 
Fellow – Faculty of Pharmaceutical Medicine (UK)
  • Fellow – Faculty of Pain Medicine, ANZCA
  • 
Senior Consultant – Pain Management Unit, RAH
  • 
Senior Consultant – Pain Management Unit, NAHLN MD, MBBS (Adelaide)
    Authored over 130 research publications.
  • Principal Investigator in over 700 clinical pharmacology, drug interactions and special patient group studies.

Plant Science Leadership

André Devorss
Cultivation, Genetic and Process Consultant

Originally from the USA and now residing in South Australia, André Devorss is a globally recognised leader in the field of Cannabis Research and Development. His academic qualifications in Chemistry and Engineering Physics (USA) are supported by 10 years direct experience in the cultivation, extraction and formulation of precision Cannabis products. Mr. Devorss’ widely recognised credibility in this field led to his being awarded a Global Distinguished Talent Visa, Under MedTEC Pharma’s sponsorship, from the Australian Federal Government in 2020.

Menu